{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T21:20:22Z","timestamp":1779398422600,"version":"3.53.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100019256","name":"NIHR Great Ormond Street Hospital Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019256","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022850","name":"Little Princess Trust","doi-asserted-by":"publisher","award":["CCLGA 2019 27"],"award-info":[{"award-number":["CCLGA 2019 27"]}],"id":[{"id":"10.13039\/501100022850","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011692","name":"Children's Cancer and Leukaemia Group","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011692","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C1188\/A8687"],"award-info":[{"award-number":["C1188\/A8687"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019178","name":"Sociedad Espa\u00f1ola de Reumatolog\u00eda Pedi\u00e1trica","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019178","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004963","name":"Seventh Framework Programme","doi-asserted-by":"publisher","award":["261474"],"award-info":[{"award-number":["261474"]}],"id":[{"id":"10.13039\/501100004963","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004963","name":"Seventh Framework Programme","doi-asserted-by":"publisher","award":["270089"],"award-info":[{"award-number":["270089"]}],"id":[{"id":"10.13039\/501100004963","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.urolonc.2025.05.018","type":"journal-article","created":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T15:05:26Z","timestamp":1750518326000},"page":"525.e19-525.e32","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Outcome of patients with a first relapse after intermediate- or high-risk Wilms tumor, treated according to SIOP WT 2001\/UK-IMPORT study; A report from the SIOP renal tumor study group"],"prefix":"10.1016","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6466-7785","authenticated-orcid":false,"given":"Alissa","family":"Groenendijk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harm","family":"van Tinteren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald R.","family":"de Krijger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordan","family":"Vujanic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reem","family":"Al-Saadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathy","family":"Pritchard-Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gema L.","family":"Ram\u00edrez-Villar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Melchior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Godzinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens-Peter","family":"Schenk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Graf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi","family":"Segers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Sudour-Bonnange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnauld C.","family":"Verschuur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jarno","family":"Drost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Perotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Al-Jilaihawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesper","family":"Brok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marry M.","family":"van den Heuvel-Eibrink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Spreafico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annelies M.C.","family":"Mavinkurve-Groothuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.urolonc.2025.05.018_bib0001","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/S1470-2045(18)30293-6","article-title":"Relapse of Wilms' tumour and detection methods: a retrospective analysis of the 2001 Renal Tumour Study Group-International Society of Paediatric Oncology Wilms' tumour protocol database","volume":"19","author":"Brok","year":"2018","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.urolonc.2025.05.018_bib0002","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S1470-2045(03)01322-6","article-title":"Management of Wilms' tumour: current practice and future goals","volume":"5","author":"Kalapurakal","year":"2004","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.urolonc.2025.05.018_bib0003","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1055\/s-0031-1275293","article-title":"Update on relapses in unilateral nephroblastoma registered in 3 consecutive SIOP\/GPOH studies - a report from the GPOH-nephroblastoma study group","volume":"223","author":"Furtw\u00e4ngler","year":"2011","journal-title":"Klin Padiatr"},{"issue":"5","key":"10.1016\/j.urolonc.2025.05.018_bib0004","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/pbc.20822","article-title":"Treatment of Wilms tumor relapsing after initial treatment with vincristine and actinomycin D: a report from the National Wilms Tumor Study Group","volume":"48","author":"Green","year":"2007","journal-title":"Pediatr Blood Cancer"},{"issue":"13","key":"10.1016\/j.urolonc.2025.05.018_bib0005","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.3390\/cancers13133142","article-title":"Prognostic factors for Wilms Tumor recurrence: a review of the literature","volume":"13","author":"Groenendijk","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.urolonc.2025.05.018_bib0006","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/pbc.21267","article-title":"Treatment of Wilms tumor relapsing after initial treatment with vincristine, actinomycin D, and doxorubicin. A report from the National Wilms Tumor Study Group","volume":"50","author":"Malogolowkin","year":"2008","journal-title":"Pediatr Blood Cancer"},{"issue":"12","key":"10.1016\/j.urolonc.2025.05.018_bib0007","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/nrurol.2017.163","article-title":"Position paper: rationale for the treatment of Wilms tumour in the UMBRELLA SIOP-RTSG 2016 protocol","volume":"14","author":"van den Heuvel-Eibrink","year":"2017","journal-title":"Nat Rev Urol"},{"issue":"12","key":"10.1016\/j.urolonc.2025.05.018_bib0008","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1586\/era.09.159","article-title":"Treatment of relapsed Wilms tumors: lessons learned","volume":"9","author":"Spreafico","year":"2009","journal-title":"Expert Rev Anticancer Ther"},{"issue":"3","key":"10.1016\/j.urolonc.2025.05.018_bib0009","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.30153","article-title":"Advances in the clinical management of high-risk Wilms tumors","volume":"70","author":"Ortiz","year":"2023","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"10.1016\/j.urolonc.2025.05.018_bib0010","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1093\/annonc\/mdf028","article-title":"Ifosfamide, carboplatin and etoposide in children with poor-risk relapsed Wilms' tumor: a Children's Cancer Group report","volume":"13","author":"Abu-Ghosh","year":"2002","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.urolonc.2025.05.018_bib0011","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/pbc.21524","article-title":"Treatment of high-risk relapsed Wilms tumor with dose-intensive chemotherapy, marrow-ablative chemotherapy, and autologous hematopoietic stem cell support: experience by the Italian Association of Pediatric Hematology and Oncology","volume":"51","author":"Spreafico","year":"2008","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"10.1016\/j.urolonc.2025.05.018_bib0012","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ejca.2012.07.010","article-title":"An international strategy to determine the role of high dose therapy in recurrent Wilms' tumour","volume":"49","author":"Ha","year":"2013","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.urolonc.2025.05.018_bib0013","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ejca.2020.11.012","article-title":"Unmet needs for relapsed or refractory Wilms tumour: mapping the molecular features, exploring organoids and designing early phase trials - a collaborative SIOP-RTSG, COG and ITCC session at the first SIOPE meeting","volume":"144","author":"Brok","year":"2021","journal-title":"Eur J Cancer"},{"issue":"432","key":"10.1016\/j.urolonc.2025.05.018_bib0014","first-page":"2005","article-title":"Anti-tumor activity of topotecan against Wilms tumor: translation of a xenograft model to a phase II study","volume":"45","author":"Dome","year":"2005","journal-title":"Pediatr Blood Cancer"},{"issue":"2","key":"10.1016\/j.urolonc.2025.05.018_bib0015","doi-asserted-by":"crossref","first-page":"e26851","DOI":"10.1002\/pbc.26849","article-title":"Irinotecan for relapsed Wilms tumor in pediatric patients: SIOP experience and review of the literature- a report from the SIOP Renal Tumor Study Group","volume":"65","author":"Hol","year":"2018","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"10.1016\/j.urolonc.2025.05.018_bib0016","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/pbc.25357","article-title":"Treatment of relapsed Wilms tumour (WT) patients: experience with topotecan. A report from the SIOP Renal Tumour Study Group (RTSG)","volume":"62","author":"Mavinkurve-Groothuis","year":"2015","journal-title":"Pediatr Blood Cancer"},{"issue":"21","key":"10.1016\/j.urolonc.2025.05.018_bib0017","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1200\/JCO.2007.10.9298","article-title":"Topotecan is active against Wilms' tumor: results of a multi-institutional phase II study","volume":"25","author":"Metzger","year":"2007","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.urolonc.2025.05.018_bib0018","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/pbc.24785","article-title":"Treatment of multiply relapsed wilms tumor with vincristine, irinotecan, temozolomide and bevacizumab","volume":"61","author":"Venkatramani","year":"2014","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.urolonc.2025.05.018_bib0019","series-title":"Results of UK children\u2019s cancer and leukemia group (CCLG) protocol for relapsed wilms tumor (UKWR): unified relapse strategy improves outcome","year":"2008"},{"issue":"2","key":"10.1016\/j.urolonc.2025.05.018_bib0020","first-page":"463","article-title":"Outcome of relapses of nephroblastoma in patients registered in the SIOP\/GPOH trials and studies","volume":"20","author":"Reinhard","year":"2008","journal-title":"Oncol Rep"},{"key":"10.1016\/j.urolonc.2025.05.018_bib0021","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ejca.2021.12.014","article-title":"Outcome of SIOP patients with low- or intermediate-risk Wilms tumour relapsing after initial vincristine and actinomycin-D therapy only - the SIOP 93-01 and 2001 protocols","volume":"163","author":"Groenendijk","year":"2022","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.urolonc.2025.05.018_bib0022","unstructured":"Therneau T A package for survival analysis in R. R package version 3.5-7 ed2023. Available via: https:\/\/CRAN.R-project.org\/package=survival"},{"key":"10.1016\/j.urolonc.2025.05.018_bib0023","unstructured":"Kassambara A, Kosinski M, BP survminer: Drawing survival curves using 'ggplot2\u2032. R package version 0.4.9 ed2021. Available via: https:\/\/CRAN.R-project.org\/package=survminer"},{"key":"10.1016\/j.urolonc.2025.05.018_bib0024","unstructured":"Harrison E, Drake T, Ots R. finalfit: quickly create elegant regression results tables and plots when modelling. R package version 1.0.6 ed2023. Available via: https:\/\/CRAN.R-project.org\/package=finalfit"},{"key":"10.1016\/j.urolonc.2025.05.018_bib0025","series-title":"An r companion to applied regression","author":"Fox","year":"2011"},{"key":"10.1016\/j.urolonc.2025.05.018_bib0026","unstructured":"Samir P., Andrea L., Luke E.P., Mary Frances M., Arnold P., John A.K. Long-term toxicities among Wilms Tumor survivors editor. In: Thomas J.F., editor. Radiation therapy. Rijeka: IntechOpen; London, United Kingdom; 2023. Ch. 7."},{"issue":"1","key":"10.1016\/j.urolonc.2025.05.018_bib0027","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1038\/s41467-020-15155-6","article-title":"An organoid biobank for childhood kidney cancers that captures disease and tissue heterogeneity","volume":"11","author":"Calandrini","year":"2020","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.urolonc.2025.05.018_bib0028","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/00043426-200203000-00007","article-title":"Improved survival for patients with recurrent Wilms tumor: the experience at St. Jude Children's Research Hospital","volume":"24","author":"Dome","year":"2002","journal-title":"J Pediatr Hematol Oncol"},{"issue":"1","key":"10.1016\/j.urolonc.2025.05.018_bib0029","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.suronc.2007.08.011","article-title":"Surgical implications for liver metastases in nephroblastoma\u2013data from the SIOP\/GPOH study","volume":"17","author":"Fuchs","year":"2008","journal-title":"Surg Oncol"},{"issue":"6","key":"10.1016\/j.urolonc.2025.05.018_bib0030","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/0022-3468(91)90021-K","article-title":"The role of surgical excision in the management of relapsed Wilms' tumor patients with pulmonary metastases: a report from the National Wilms' Tumor Study","volume":"26","author":"Green","year":"1991","journal-title":"J Pediatr Surg"},{"issue":"8","key":"10.1016\/j.urolonc.2025.05.018_bib0031","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0221373","article-title":"Prognostic significance of age in 5631 patients with Wilms tumour prospectively registered in International Society of Paediatric Oncology (SIOP) 93-01 and 2001","volume":"14","author":"Hol","year":"2019","journal-title":"PLoS One"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143925002145?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143925002145?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T17:33:23Z","timestamp":1762364003000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143925002145"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":31,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S1078143925002145"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2025.05.018","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcome of patients with a first relapse after intermediate- or high-risk Wilms tumor, treated according to SIOP WT 2001\/UK-IMPORT study; A report from the SIOP renal tumor study group","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2025.05.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}